MicroRNA dysregulation in schizophrenia

Neurobiology of Disease

Volumn 46, Issue 2, 2012, Pages 263-271

  Beveridge, Natalie J ^a,b   Cairns, Murray J ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

Author keywords

Gene silencing; MicroRNA; Neuropathology; Postmortem; Schizophrenia

Indexed keywords

DIZOCILPINE; HALOPERIDOL; LITHIUM; MICRORNA; MICRORNA 128A; MICRORNA 128B; MICRORNA 144; MICRORNA 199A; MICRORNA 219; MICRORNA 221; MICRORNA 24A; MICRORNA 30C; MICRORNA 34A; MICRORNA LET 7B; MICRORNA LET 7C; UNCLASSIFIED DRUG; VALPROIC ACID;

AUTOPSY; BIPOLAR DISORDER; BRAIN CORTEX; COMPUTER PREDICTION; DISEASE ASSOCIATION; DISEASE MARKER; DOWN REGULATION; DRUG MECHANISM; DRUG TARGETING; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; GENE TARGETING; GENETIC ALGORITHM; GENETIC ASSOCIATION; HUMAN; NONHUMAN; ONLINE ANALYSIS; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; RNA SYNTHESIS; SCHIZOPHRENIA; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; BRAIN; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MICRORNAS; NERVE NET; SCHIZOPHRENIA;

EID: 84859500144     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.12.029     Document Type: Review

References (67)

1. Abelson J.F., et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005, 310:317-320.
2. Bassett A.S., et al. The schizophrenia phenotype in 22q11 deletion syndrome. Am. J. Psychiatry 2003, 160:1580-1586.
3. Begemann M., et al. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Arch. Gen. Psychiatry 2010, 67:879-888.
4. Beveridge N.J., et al. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum. Mol. Genet. 2008, 17:1156-1168.
5. Beveridge N.J., et al. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol. Psychiatry 2010, 15:1176-1189.
6. Blow M.J., et al. RNA editing of human microRNAs. Genome Biol. 2006, 7:R27.
7. Cao X., et al. Noncoding RNAs in the mammalian central nervous system. Annu. Rev. Neurosci. 2006, 29:77-103.
8. Cogswell J.P., et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 2008, 14:27-41.
9. Cox M.B., et al. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One 2010, 5:e12132.
10. Cuellar T.L., et al. Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:5614-5619.
11. Dennis G., et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003, 4:P3.
12. Enright A.J., et al. MicroRNA targets in Drosophila. Genome Biol. 2003, 5:R1.
13. Fallin M.D., et al. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am. J. Hum. Genet. 2005, 77:918-936.
14. Fenelon K., et al. Deficiency of Dgcr8, a gene disrupted by the 22q11. 2 microdeletion, results in altered short-term plasticity in the prefrontal cortex. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:4447-4452.
15. Feng J., et al. Evidence for X-Chromosomal Schizophrenia Associated with microRNA Alterations. PLoS One 2009, 4:e6121.
16. Friston K.J. The disconnection hypothesis. Schizophr. Res. 1998, 30:115-125.
17. Gardiner E., Beveridge N.J., Wu J.Q., Carr V., Scott R.J., Tooney P.A., Cairns M.J. Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells. Mol. Psychiatry 2011, 2011 Jul 5. doi:10.1038/mp.2011.78.
18. Gebauer F., et al. Molecular mechanisms of translational control. Nat. Rev. Mol. Cell Biol. 2004, 5:827-835.
19. Griffiths-Jones S., et al. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006, 34:D140-D144.
20. Guo S.Z., et al. A case-control association study between the GRID1 gene and schizophrenia in the Chinese Northern Han population. Schizophr. Res. 2007, 93:385-390.
21. Han J., et al. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 2006, 125:887-901.
22. Hansen T., et al. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One 2007, 2:e873.
23. Hebert S.S., et al. Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci. 2009, 32:199-206.
24. Hon L.S., et al. The roles of binding site arrangement and combinatorial targeting in microRNA repression of gene expression. Genome Biol. 2007, 8:R166.
25. Jin P., et al. RNA and microRNAs in fragile X mental retardation. Nat. Cell Biol. 2004, 6:1048-1053.
26. Karayiorgou M., et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:7612-7616.
27. Kawahara Y., et al. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep. 2007, 8:763-769.
28. Kim J., et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 2007, 317:1220-1224.
29. Kim A.H., et al. MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr. Res. 2010, 124:183-191.
30. Kiriakidou M., et al. A combined computational-experimental approach predicts human microRNA targets. Genes Dev. 2004, 18:1165-1178.
31. Kocerha J., et al. MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc. Natl. Acad. Sci. 2009, 106:3507-3512.
32. Krek A., et al. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
33. Lai C.-Y., et al. MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PLoS One 2011, 6:e21635.
34. Lee R.C., et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
35. Lewis B.P., et al. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
36. Lewis B.P., et al. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
37. Megraw M., et al. miRGen: a database for the study of animal microRNA genomic organization and function. Nucleic Acids Res. 2007, 35:D149-D155.
38. Mellios N. A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex - Supp. Material. Hum. Mol. Genet. 2008, 1-17.
39. Mellios N., et al. Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biol. Psychiatry 2009, 65:1006-1014.
40. Mellios N., et al. Gender-Specific reduction of estrogen-sensitive small RNA, miR-30b, in subjects with schizophrenia. Schizophr. Bull. 2010.
41. Moreau M.P., et al. Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol. Psychiatry 2011, 69:188-193.
42. Murphy K.C., et al. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch. Gen. Psychiatry 1999, 56:940-945.
43. Nelson P.T., et al. MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. J. Alzheimers Dis. 2010, 21:75-79.
44. Perkins D.O., et al. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol. 2007, 8:R27.
45. Pillai R.S., Bhattacharyya S.N., Artus C.G., Zoller T., Cougot N., Basyuk E., et al. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 2005, 309(5740):1573-1576.
46. Rees E., Moskvina V., Owen M.J., O'Donovan M.C., Kirov G. De novo rates and selection of schizophrenia-associated copy number variants. Biol Psychiatry 2011, 70(12):1109-1114.
47. Santarelli D.M., et al. Upregulation of dicer and MicroRNA expression in the dorsolateral prefrontal cortex Brodmann Area 46 in schizophrenia. Biol. Psychiatry 2011, 69:180-187.
48. Schipper H.M., et al. MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul. Syst. Bio. 2007, 1:263-274.
49. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 1-10. Schizophrenia Psychiatric Genome-Wide Association Study GWAS Consortium.
50. Schofield C.M., et al. Monoallelic deletion of the microRNA biogenesis gene Dgcr8 produces deficits in the development of excitatory synaptic transmission in the prefrontal cortex. Neural Dev. 2011, 6:11.
51. Sethupathy P., et al. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat. Methods 2006, 3:881-886.
52. Smrt R.D., et al. MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells 2010, 28:1060-1070.
53. Stark K.L., et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 2008, 40:751-760.
54. Sun G., et al. SNPs in human miRNA genes affect biogenesis and function. RNA 2009, 15:1640-1651.
55. Szulwach K.E., et al. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J. Cell Biol. 2010, 189:127-141.
56. Tabares-Seisdedos R., et al. Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer. Mol. Psychiatry 2009, 14:563-589.
57. Thomson J.M., et al. A custom microarray platform for analysis of microRNA gene expression. Nat. Methods 2004, 1:47-53.
58. Thomson J.M., et al. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 2006, 20:2202-2207.
59. Wang W.X., et al. miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am. J. Pathol. 2010, 177:334-345.
60. Xie X., et al. Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature 2005, 434:338-345.
61. Xu B., et al. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat. Genet. 2008, 40:880-885.
62. Xu Y., et al. MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia. Schizophr. Res. 2010, 119:219-227.
63. Yang W., et al. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat. Struct. Mol. Biol. 2006, 13:13-21.
64. Zeng Y., et al. Efficient processing of primary microRNA hairpins by Drosha requires flanking nonstructured RNA sequences. J. Biol. Chem. 2005, 280:27595-27603.
65. Zeng Y., et al. Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J. 2005, 24:138-148.
66. Zhou R., et al. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 2009, 34:1395-1405.
67. Zhu Y., et al. A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene. Schizophr. Res. 2009, 1-4.